SCHEMBL3384595

SCHEMBL3384595

CN1CCc2cc(Nc3ncc(C4CC4)c(NCCCN)n3)ccc2C1

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ULK1 O75385 3/20 0.75
ULK2 Q8IYT8 3/20 0.75
STK17A Q9UEE5 3/20 0.59
CHEK1 O14757 11/20 0.58
FLT3 P36888 11/20 0.58
STK17B O94768 2/20 0.57
TBK1 Q9UHD2 3/20 0.56
KIT P10721 3/20 0.56
AURKA O14965 1/20 0.56
RPS6KA5 O75582 1/20 0.56
RPS6KA4 O75676 1/20 0.56
RPS6KB1 P23443 1/20 0.56
CDK2 P24941 1/20 0.56
RPS6KA3 P51812 1/20 0.56
RPS6KA2 Q15349 1/20 0.56
RPS6KA1 Q15418 1/20 0.56
IRAK4 Q9NWZ3 1/20 0.56
RPS6KB2 Q9UBS0 1/20 0.56
RPS6KA6 Q9UK32 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3385882 0.97 ULK1 (0.71) ULK1ULK2STK17ACHEK1FLT3
SCHEMBL27087860 0.90 ULK1 (0.73) ULK1ULK2STK17ACHEK1FLT3
SCHEMBL29989851 0.90 ULK1 (0.73) ULK1ULK2STK17ACHEK1FLT3
SCHEMBL27087849 0.90 ULK1 (0.73) ULK1ULK2STK17ACHEK1FLT3
SCHEMBL3384590 0.87 ULK1 (0.74) ULK1ULK2CHEK1FLT3TBK1
SCHEMBL27402989 0.87 ULK1 (0.72) ULK1ULK2STK17ACHEK1FLT3
SCHEMBL29989356 0.87 ULK1 (0.72) ULK1ULK2STK17ACHEK1FLT3
SCHEMBL29990151 0.86 ULK1 (0.71) ULK1ULK2STK17ACHEK1FLT3
SCHEMBL27087794 0.86 ULK1 (0.71) ULK1ULK2STK17ACHEK1FLT3
SCHEMBL13431972 0.84 ULK1 (1.00) ULK1ULK2STK17ATBK1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056524-A1 Compound MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056524-A1 Compound NR3C2, NR3C1, NR2E3 ULK1 2369/4885ULK2 1695/4885STK17A 381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.